Efficacy of contrast-enhanced EUS for lymphadenopathy: a prospective multicenter pilot study (with videos)

• Published in: Gastrointestinal endoscopy 2019-08, Vol.90 (2), p.242-250
• Main Authors: Yoshida, Kensaku, Iwashita, Takuji, Uemura, Shinya, Mita, Naoki, Iwata, Keisuke, Mukai, Tsuyoshi, Yasuda, Ichiro, Shimizu, Masahito
• Format: Article
• Language: English
• Subjects: Abdomen; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Endoscopic Ultrasound-Guided Fine Needle Aspiration - methods; Female; Humans; Lymphadenopathy - pathology; Male; Mediastinum; Middle Aged; Pilot Projects; Prospective Studies
• ISSN: 0016-5107; 1097-6779
• DOI: 10.1016/j.gie.2019.03.015

Contrast-enhanced EUS (CE-EUS) allows qualitative and quantitative evaluation based on real-time perfusion imaging and may improve the diagnostic capability. The aim of this study was to evaluate the efficacy of CE-EUS in differentiating malignant from benign lymphadenopathy. Patients undergoing EUS-FNA for abdominal or mediastinal lymphadenopathy were prospectively enrolled. The echofeatures on B-mode EUS and the vascular and enhancement patterns in CE-EUS were qualitatively evaluated. The echo intensity change during 60 seconds in the lymphadenopathy was quantitatively evaluated by time intensity curve (TIC) analysis. One hundred consecutive patients with 70 malignant and 30 benign lesions were enrolled. The sensitivity, specificity, and accuracy of the qualitative assessment in B-mode EUS were 77%, 17%, and 59%, respectively. When the heterogeneous enhancement was defined as malignancy, the sensitivity, specificity, and accuracy of the qualitative assessment in CE-EUS were 67%, 87%, and 73%, respectively. In TIC analysis, the velocity of reduction for homogeneous lesions showed a significant difference between malignant and benign lesions (P = .0011), and the receiver operating characteristic analysis showed an optimal cut-off value of .149 dB/s. The sensitivity, specificity, and diagnostic capabilities of CE-EUS for malignancy were improved to 89%, 77%, and 85%, respectively, on combining the qualitative and quantitative analyses. With regard to diagnostic accuracy, CE-EUS with combined qualitative and quantitative analyses was significantly higher than those of B-mode EUS or qualitative assessment of CE-EUS. CE-EUS with the combined qualitative and quantitative analyses for lymphadenopathy might be useful to complement regular EUS and EUS-FNA. (Clinical trial registration number: UMIN000024298.) [Display omitted]